XML 55 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting (Tables)
6 Months Ended
Dec. 31, 2021
Segment Reporting  
Segment financial information

Three Months Ended

Six Months Ended

December 31, 

December 31, 

    

2021

    

2020

2021

    

2020

(In thousands)

(In thousands)

Consolidated revenue:

  

 

  

  

 

  

Aytu BioPharma

$

14,643

$

7,212

$

28,526

$

12,964

Aytu Consumer Health

 

8,482

 

7,935

 

16,496

 

15,703

Consolidated revenue

$

23,125

$

15,147

$

45,022

$

28,667

Consolidated net loss:

 

  

 

  

 

  

 

  

Aytu BioPharma

$

(9,591)

$

(8,268)

$

(36,048)

$

(11,218)

Aytu Consumer Health

 

(1,957)

 

(1,257)

 

(3,351)

 

(2,613)

Consolidated net loss

$

(11,548)

$

(9,525)

$

(39,399)

$

(13,831)

December 31, 

June 30, 

2021

2021

(In thousands)

Total assets:

Aytu BioPharma

$

194,419

$

236,449

Aytu Consumer Health

 

29,405

 

29,219

Consolidated assets

$

223,824

$

265,668